SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CLZR:a potential 10 bagger?

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Capitalizer who wrote (164)8/24/1999 11:11:00 AM
From: Bob Davis   of 315
 
Candela Corporation (NASDAQ:CLZR) has just announced its year-end financial results. Kaboooom!

"Profits for the quarter reached $3,281,000 or $0.50 per diluted share compared to $0.19 for the same quarter last year - an increase of 163%. For the full year, the Company had profits of $7,491,000 or $1.22 per diluted share versus a loss of $4,452,000 or $0.81 per diluted share a year earlier."

I have said very little about CLZR over the last few months, simply because my earlier statements still "covered the subject." I knew that CLZR would speak for itself...and it has! A lot more investors have now heard about it, and it is up 1 1/8 this morning.

A Flash Report will be published on the Napeague Letter web site later today. The URL for the Napeague web site can be found by clicking on my SI Profile.

Bob Davis
The Napeague Letter
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext